SNGX - SOLIGENIX, INC.

1.19
0.040   3.361%

Share volume: 93,109
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$1.15
0.04
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
22%
Profitability 25%
Dept financing 14%
Liquidity 45%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.71%
1 Month
6.25%
3 Months
-24.68%
6 Months
-55.26%
1 Year
-49.70%
2 Year
-90.59%
Key data
Stock price
$1.19
P/E Ratio 
0.00
DAY RANGE
$1.12 - $1.20
EPS 
-$4.26
52 WEEK RANGE
$1.02 - $6.23
52 WEEK CHANGE
-$47.35
MARKET CAP 
4.971 M
YIELD 
N/A
SHARES OUTSTANDING 
10.086 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-09-2025
BETA 
1.47
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$135,876
AVERAGE 30 VOLUME 
$137,523
Company detail
CEO: Christopher J. Schaber
Region: US
Website: www.soligenix.com
Employees: 20
IPO year: 2009
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Soligenix, Inc. focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions.

Recent news